Lung Cancer (NSCLC)NCT07237503
THE EFFECT OF CALISTHENIC EXERCISES ON FATIGUE AND EXERCISE ATTITUDES IN PATIENTS WITH LUNG CANCER
A study testing Exercise and Home based exercise in people with Lung Cancer (NSCLC) and Physiotherapy, run by Hasan Kalyoncu University at 1 site in Turkey (Türkiye).
Trial summary
Purpose: This study was carried out to investigate fatigue and exercise barriers of calisthenic exercises in patients with lung cancer. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Lung Cancer (NSCLC), Physiotherapy, Fatigue in Cancer Survivors
- What is being tested?
- Exercise and Home based exercise
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 33 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Jul 2025to 15 Jun 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- To be between the ages of 18-65
- Patients with lung cancer who continue to receive chemotherapy, radiotherapy or immunotherapy (smart drugs)
- Patients reporting fatigue of 3 or more on the Modified Borg Scale
Who cannot join
- Uncontrolled hypertension, diabetes mellitus, heart failure and atrial fibrillation
- Any acute infection at the time of assessment
- Those with orthopaedic, neurological, psychological, etc. problems that may limit the assessments
Trial locations and contacts
1 site in 1 country.
About this study
Purpose: This study was carried out to investigate fatigue and exercise barriers of calisthenic exercises in patients with lung cancer.
- Being tested
- Exercise, Home based exercise
- Keywords
- Lung cancer, exercise, fatigue, physiotherapist
- Medical subject headings
- Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Motor Activity, Fatigue
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ExerciseBehavioural
Patients in Group 1 were exercised 3 days a week for 8 weeks at 50-60% of maximal heart rate for 40 min, accompanied by a physiotherapist.
Home based exerciseBehavioural
Patients in Group 2 were given an exercise booklet and followed up with weekly controls.
| Study group | Role | What they receive |
|---|---|---|
| Physiotherapist-Led Exercise | Experimental | Patients in Group 1 were exercised 3 days a week for 8 weeks at 50-60% of maximal heart rate for 40 min, accompanied by a physiotherapist. Receives: Behavioral: Exercise |
| Home Exercise Group | Active comparator | . Patients in Group 2 were given an exercise booklet and followed up with weekly controls. Receives: Behavioral: Home based exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Exercise benefits and barriers
the perception of disability decreases in the group exercising with a physiotherapist
Measured: 2 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Nov 2025
- Study start15 Jul 2025
- Primary completion1 Apr 2026 (estimated)
- Study completion15 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Lung Cancer (NSCLC)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- During the 8-week period, both groups completed exercise training three times a week at low to moderate intensity (50-60% of maximal heart rate). In the first week, patients in both groups were allowed to exercise as much as they could tolerate, with more frequent rest intervals provided. Starting from the third week, as patients' tolerance improved, rest intervals were reduced and the number of repetitions was adjusted to 10. By the second month, for patients who were able to tolerate more, the number of repetitions was increased to 12, and in the following week, exercises were planned as 2 sets for suitable patients. In the Physiotherapist-Led Exercise group, the exercise sessions were conducted under the supervision of a physiotherapist, and patients' respiratory rate, fatigue severity, blood pressure, and pain were regularly monitored. In the Home Exercise Training group, the same exercises were demonstrated practically during the first session, and patients were instructed to re
- Masking
- None (open label)
- Enrolment
- 33 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hasan Kalyoncu University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kardelen HATIMOĞULLARI, Hasan Kalyoncu University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07237503
- Sponsor's protocol ID
- 2025/051
- Status last verified
- Sep 2025
- First submitted
- 7 Jul 2025
- Last updated
- 19 Nov 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- THE EFFECT OF CALISTHENIC EXERCISES ON FATIGUE AND EXERCISE ATTITUDES IN PATIENTS WITH LUNG CANCER
- ClinicalTrials.gov ID
- NCT07237503
- Acronym / sponsor ID
- 2025/051
- Keywords
- Lung cancer, exercise, fatigue, physiotherapist
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 33 participants (estimated)
- Lead sponsor
- Hasan Kalyoncu UniversityUniversity, hospital or other
- Study start
- 15 Jul 2025 (actual)
- Primary completion
- 1 Apr 2026 (estimated)
- Study completion
- 15 Jun 2026 (estimated)
- First posted
- 19 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Purpose: This study was carried out to investigate fatigue and exercise barriers of calisthenic exercises in patients with lung cancer.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- During the 8-week period, both groups completed exercise training three times a week at low to moderate intensity (50-60% of maximal heart rate). In the first week, patients in both groups were allowed to exercise as much as they could tolerate, with more frequent rest intervals provided. Starting from the third week, as patients' tolerance improved, rest intervals were reduced and the number of repetitions was adjusted to 10. By the second month, for patients who were able to tolerate more, the number of repetitions was increased to 12, and in the following week, exercises were planned as 2 sets for suitable patients. In the Physiotherapist-Led Exercise group, the exercise sessions were conducted under the supervision of a physiotherapist, and patients' respiratory rate, fatigue severity, blood pressure, and pain were regularly monitored. In the Home Exercise Training group, the same exercises were demonstrated practically during the first session, and patients were instructed to re
| Arm | Type | Receives |
|---|---|---|
| Physiotherapist-Led Exercise | Experimental | Behavioral: ExercisePatients in Group 1 were exercised 3 days a week for 8 weeks at 50-60% of maximal heart rate for 40 min, accompanied by a physiotherapist. |
| Home Exercise Group | Active comparator | Behavioral: Home based exercise. Patients in Group 2 were given an exercise booklet and followed up with weekly controls. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- To be between the ages of 18-65
- Patients with lung cancer who continue to receive chemotherapy, radiotherapy or immunotherapy (smart drugs)
- Patients reporting fatigue of 3 or more on the Modified Borg Scale
Key exclusion criteria (3 listed)
- Uncontrolled hypertension, diabetes mellitus, heart failure and atrial fibrillation
- Any acute infection at the time of assessment
- Those with orthopaedic, neurological, psychological, etc. problems that may limit the assessments
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ExercisePatients in Group 1 were exercised 3 days a week for 8 weeks at 50-60% of maximal heart rate for 40 min, accompanied by a physiotherapist. | Behavioural | Physiotherapist-Led Exercise |
| Home based exercisePatients in Group 2 were given an exercise booklet and followed up with weekly controls. | Behavioural | Home Exercise Group |
Primary outcome
Exercise benefits and barriers
Time frame: 2 month
the perception of disability decreases in the group exercising with a physiotherapist
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Nov 2025.
- Individual participant dataSharing planned: No
Related trials for Lung Cancer (NSCLC)
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
A Prospective ,Multicenter ,Non-interventional ,Real-world Study Observing Changes in Molecular Markers Osimertinib Targeted Therapy in EGFRm NSCLC
Non Small Cell Lung Cancer
RecruitingPhase 3
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Active, not recruitingPhase 2
Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer
Metastatic Lung Cancer, Advanced Non Small Cell Lung Cancer
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise and Home based exercise in people with Lung Cancer (NSCLC) and Physiotherapy, run by Hasan Kalyoncu University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 19 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Exercise benefits and barriers (time frame: 2 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2025.